We are thrilled to announce that CatSci will be attending TIDES Europe 2024 in Hamburg this week, joining global innovators and leaders in the oligonucleotide and peptides therapeutic space.
Representing CatSci will be our Group Lead, Dr Aled Williams, who is looking forward to engaging with industry peers to discuss ground-breaking approaches in process research and development for oligonucleotide and peptide projects. Aled is excited to share CatSci’s unique capabilities in oligo processes, as well as addressing some of the field’s most pressing challenges.
As RNA-based therapies continue to gain traction as transformative tools in personalised medicine, CatSci remains committed to driving the field forward. We are excited to explore new ways to streamline production, enhance efficiency, and ensure that these life-changing therapies reach patients who need them most, both rapidly and sustainably. Discover more about our oligos capabilities here.
We also recently won a prestigious SMART Capital Equipment grant from the Welsh Government to open a second state-of-the-art oligonucleotides laboratory, demonstrating CatSci’s commitment to accelerating the development of cutting-edge novel RNA and DNA-based therapeutics. Read about it here.
If you’re attending TIDES Europe 2024, connect with Aled to discuss how CatSci can support your journey in oligonucleotide and peptide development.